Table 2.

Cell cycle analysis of L540cy HD cells




Sub-G1 R1

G1 R2

S-phase R3

G2 R4

Sub-G2 R5
12 h       
    Untreated   2.0   47.9   37.6   9.7   1.9  
    cAC10   2.2   35.3   52.3   7.5   1.3  
    cAC10-vcMMAE   2.5   5.7   36.5   46.5   2.5  
    clgG-vcMMAE   1.6   36.1   46.4   12.3   2.1  
24 h       
    Untreated   1.6   38.5   47.4   7.7   4.8  
    cAC10   1.9   39.3   44.8   11.8   2.2  
    cAC10-vcMMAE   19.2   10.2   27.8   28.3   6.6  
    clgG-vcMMAE   4.6   31.5   38.5   18.9   3.2  
48 h       
    Untreated   1.9   43.7   39.3   11.6   3.1  
    cAC10   2.8   46.7   40.5   0.4   10.4  
    cAC10-vcMMAE   53.1   1.5   26.3   0.9   1.0  
    clgG-vcMMAE
 
5.5
 
49.0
 
26.9
 
11.9
 
6.1
 



Sub-G1 R1

G1 R2

S-phase R3

G2 R4

Sub-G2 R5
12 h       
    Untreated   2.0   47.9   37.6   9.7   1.9  
    cAC10   2.2   35.3   52.3   7.5   1.3  
    cAC10-vcMMAE   2.5   5.7   36.5   46.5   2.5  
    clgG-vcMMAE   1.6   36.1   46.4   12.3   2.1  
24 h       
    Untreated   1.6   38.5   47.4   7.7   4.8  
    cAC10   1.9   39.3   44.8   11.8   2.2  
    cAC10-vcMMAE   19.2   10.2   27.8   28.3   6.6  
    clgG-vcMMAE   4.6   31.5   38.5   18.9   3.2  
48 h       
    Untreated   1.9   43.7   39.3   11.6   3.1  
    cAC10   2.8   46.7   40.5   0.4   10.4  
    cAC10-vcMMAE   53.1   1.5   26.3   0.9   1.0  
    clgG-vcMMAE
 
5.5
 
49.0
 
26.9
 
11.9
 
6.1
 

Flow cytometry data are shown in Figure 5 and in comparable plots of untreated cells.

Cells treated with cAC10 were analyzed using CellQuest Software (Becton Dickinson) to determine the percentages of cells in regions R1 through R5.

or Create an Account

Close Modal
Close Modal